4 Dow Stocks Every Retiree Should Own
It's arguably the bluest of the blue-chip stock indexes, dating back to the 19th century.
It's arguably the bluest of the blue-chip stock indexes, dating back to the 19th century. The Dow Jones industrial average is a bastion of large, stable companies that pay dividends and represent some of the very best firms in their respective industries. That's why a retiree looking for a high-quality company with a dependable income stream would be wise to consult the Dow. If we had to pick just four of the 30 stocks that make up the Dow, we would focus on names with some combination of high or fast-rising dividends and promising business prospects. Another requirement would be that the stock price be reasonable relative to the company's expected future earnings. And if management is sitting on loads of cash that can be returned to shareholders through dividend hikes and share buybacks, so much the better. Based on a mix of those criteria, these four Dow components stand out as must-have holdings for retirees.
Disclaimer
All prices and other data are as of January 3, 2017. Price/earnings ratios are based on the average of analysts’ forecasts for calendar 2017, as compiled by Zacks Investment Research. Stocks are listed alphabetically.
Apple
- Symbol: AAPL
- Share price: $115.44
- Dividend yield: 1.9%
- Price/earnings ratio: 13
It’s somewhat unusual to look to the technology sector for dividends and value, but Apple is no ordinary company. It hauled in $215.6 billion in sales and $45.7 billion in profits in the fiscal year that ended in September 2016—more revenues and earnings in a year than just about any other company in the world. Apple’s hoard of cash and securities has swollen to $67.3 billion. The company has another $170 billion in long-term investments. It is now so cash-rich and profitable that it can afford to reward shareholders in two ways: buy back massive quantities of its own shares, which boosts the per-share earnings of the shares that remain outstanding; and hike its dividend, which it has raised at an annualized pace of 10% over the past four years.
Apple might never achieve the growth rates it enjoyed when the iPhone was first ascendant. Profits, in fact, dipped 14.4% in fiscal 2016, compared with a year earlier. But analysts see earnings rising 9% in fiscal 2017 and 10% the following year, fueled by sales of a new iPhone that Apple will likely launch in late 2017 to coincide with its 10th anniversary on the market. Investors aren’t paying much for that growth, with the stock trading at about 13 times earnings, well below the P/E ratio of 17 for Standard & Poor’s 500-stock index. More dividend hikes are likely as Apple continues to rake in cash.
Merck
- Symbol: MRK
- Share price: $60.31
- Dividend yield: 3.1%
- Price/earnings ratio: 15
Health care stalwart Merck hasn’t missed a quarterly dividend payment in more than three decades. A recent four-year streak of dividend increases looks likely to continue. And Merck’s growth prospects appear compelling. Years of acquisitions, plus research and development, are resulting in a slew of successful drugs now on the market. Cancer medicine Keytruda is an ongoing hit, for example, and Merck has more potential winners in the works with 24 drugs in the latter stages of development. Analysts, on average, believe Merck's earnings per share rose 5% in 2016. In the 12-month period that ended September 30, 2016, Merck generated $9 billion in free cash flow (cash profits, minus the capital expenditures needed to maintain the business).
Pfizer
- Symbol: PFE
- Share price: $32.87
- Dividend yield: 3.6%
- Price/earnings ratio: 13
Like Merck, Pfizer is a relatively high-yield stock. Investors worry that the company isn’t producing enough new products to overcome the loss of revenues from drugs that lose patent protection. But Pfizer has invested heavily in research and development, and made some big acquisitions that should start to produce a new wave of products. Breast cancer treatment Ibrance, blood thinner Eliquis and the pneumococcal pneumonia vaccine Prevnar 13 are just three of the company’s recent successes. And Pfizer’s lineup of drugs in development looks promising, with 94 products in the works.
The company has paid quarterly dividends consistently for decades and has a six-year history of dividend growth. Earnings per share are expected to rise just 2% next year, but the dividend looks well-covered. Analysts forecast that the company will shell out more than $7 billion in dividends in 2017, less than half the firm’s estimated net income of $15.9 billion.
Verizon Communications
- Symbol: VZ
- Share price: $54.45
- Dividend yield: 4.3%
- Price/earnings ratio: 13
Verizon Communications, formerly called Bell Atlantic, has paid dividends under its current name since 2000. It can also claim nine straight years of dividend growth. But the company has more to offer than an income stream.
Verizon is repositioning itself for a world in which mobile content and ads are ubiquitous. It purchased AOL for its digital-advertising technology in 2015 and currently has an agreement to buy Yahoo (YHOO). That deal may not go through, partly because of Yahoo’s recent disclosure of a massive data theft impacting more than 1 billion accounts. But Verizon is raking in cash from its mobile business, Fios TV service and other revenue sources. Profits should climb 4% in 2017, according to the average of analysts’ estimates. Throw in a 4.3% dividend yield and you could scoop up total returns of more than 8% over the next year if the stock keeps pace with profit growth.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Dan Burrows is Kiplinger's senior investing writer, having joined the august publication full time in 2016.
A long-time financial journalist, Dan is a veteran of SmartMoney, MarketWatch, CBS MoneyWatch, InvestorPlace and DailyFinance. He has written for The Wall Street Journal, Bloomberg, Consumer Reports, Senior Executive and Boston magazine, and his stories have appeared in the New York Daily News, the San Jose Mercury News and Investor's Business Daily, among other publications. As a senior writer at AOL's DailyFinance, Dan reported market news from the floor of the New York Stock Exchange and hosted a weekly video segment on equities.
Once upon a time – before his days as a financial reporter and assistant financial editor at legendary fashion trade paper Women's Wear Daily – Dan worked for Spy magazine, scribbled away at Time Inc. and contributed to Maxim magazine back when lad mags were a thing. He's also written for Esquire magazine's Dubious Achievements Awards.
In his current role at Kiplinger, Dan writes about equities, fixed income, currencies, commodities, funds, macroeconomics, demographics, real estate, cost of living indexes and more.
Dan holds a bachelor's degree from Oberlin College and a master's degree from Columbia University.
Disclosure: Dan does not trade stocks or other securities. Rather, he dollar-cost averages into cheap funds and index funds and holds them forever in tax-advantaged accounts.
-
Visa Is the Worst Dow Stock Wednesday. Here's Why
Visa stock is down sharply Wednesday after the credit card company came up short of revenue expectations for its fiscal Q3.
By Joey Solitro Published
-
Another Analyst Moves to the Sidelines on Tesla Stock After Earnings
Tesla stock is spiraling Wednesday after the EV maker's big earnings miss and Wall Street has been quick to weigh in. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: Mega-Cap Tech Rallies to Drag Markets Higher
Markets focused on upcoming earnings from Magnificent 7 stocks rather than chaos in D.C.
By Dan Burrows Published
-
Stock Market Today: Dow Sinks 533 Points as Big Banks, Mega Caps Slump
Goldman Sachs and Apple were two of the worst-performing blue chip stocks on Thursday.
By Karee Venema Published
-
Stock Market Today: Dow Adds 210 Points as Apple, Goldman Hit New Highs
A big rally in blue chips and some dovish Fed speak boosted the equities market Monday.
By Karee Venema Published
-
Stock Market Today: Markets Mixed as Rising Rate-Cut Bets Boost Small Caps
A surprisingly soft inflation report sparked a rotation from mega-caps into riskier names.
By Dan Burrows Published
-
Stock Market Today: Markets Surge on Dovish Remarks From Powell
The S&P 500 topped 5,600 for the first time ever, boosted by mega-cap tech stocks.
By Dan Burrows Published
-
Stock Market Today: S&P 500 and Nasdaq Hit Records as Jobs Growth Slows
An uptick in the unemployment rate amid a cooling labor market could accelerate the Fed's rate-cut timeline.
By Dan Burrows Published
-
The Top-Performing Actively Managed Funds of the Last Decade
These are the actively managed funds that have performed best over the last decade.
By Nellie S. Huang Published
-
Stock Market Today: Stocks Close Higher Ahead of Powell Speech
The main indexes kicked off the second half with a win thanks to solid gains in several mega-cap stocks.
By Karee Venema Published